Literature DB >> 24305918

Ratio between proximal/distal gastroesophageal reflux does not discriminate abnormal proximal reflux.

Sebastião Carlos Pannocchia Neto1, Fernando A M Herbella, Luciana C Silva, Marco G Patti.   

Abstract

INTRODUCTION: The threshold for pathologic proximal acid reflux is a controversial topic. Most values previously published are based on absolute numbers. We hypothesized that a relative value representing the quantitative relation between the amount of acid reflux that reaches proximal levels and the amount of distal reflux would be a more adequate parameter for defining pathologic proximal reflux.
METHODS: We studied 20 healthy volunteers (median age 30 years, 70 % women) without gastroesophageal reflux disease (GERD); 50 patients (median age 51 years, 60 % women) with esophageal symptoms of GERD (heartburn, regurgitation); and 50 patients (median age 49 years, 60 % women) with extra-esophageal symptoms of GERD. All individuals underwent manometry and dual-probe pH monitoring. GERD was defined as a DeMeester score >14.7. The proximal/distal reflux ratio was calculated for all six parameters that constitute the DeMeester score.
RESULTS: Absolute numbers for proximal reflux were not different for the three groups except for the number of episodes of reflux, which was higher for patients with GERD and esophageal symptoms than for patients with GERD and extra-esophageal symptoms (p = 0.007). The number of episodes of distal reflux reaching proximal levels was significantly higher in volunteers than in all patients with GERD and significantly higher in patients with GERD and esophageal symptoms than in those with extra-esophageal symptoms.
CONCLUSIONS: Our results suggest that the proximal/distal reflux ratio is not a good normative value for defining proximal reflux.

Entities:  

Mesh:

Year:  2014        PMID: 24305918     DOI: 10.1007/s00268-013-2341-x

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  27 in total

1.  24-H pharyngeal pH monitoring in healthy volunteers: a normative study.

Authors:  M Bove; M Ruth; L Cange; I Månsson
Journal:  Scand J Gastroenterol       Date:  2000-03       Impact factor: 2.423

2.  Acid-induced esophagobronchial-cardiac reflexes in humans.

Authors:  R A Wright; S A Miller; B F Corsello
Journal:  Gastroenterology       Date:  1990-07       Impact factor: 22.682

3.  Esophageal manometry and 24-hour pH monitoring in the diagnosis of pulmonary aspiration secondary to gastroesophageal reflux.

Authors:  M G Patti; H T Debas; C A Pellegrini
Journal:  Am J Surg       Date:  1992-04       Impact factor: 2.565

4.  Effect of laparoscopic fundoplication on gastroesophageal reflux disease-induced respiratory symptoms.

Authors:  M G Patti; M Arcerito; A Tamburini; U Diener; C V Feo; B Safadi; P Fisichella; L W Way
Journal:  J Gastrointest Surg       Date:  2000 Mar-Apr       Impact factor: 3.452

5.  Proximal sensor data from routine dual-sensor esophageal pH monitoring is often inaccurate.

Authors:  Matt McCollough; Abdul Jabbar; Robert Cacchione; Jeff W Allen; Steve Harrell; John M Wo
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

6.  Symptoms with acid and nonacid reflux may be produced by different mechanisms.

Authors:  A Agrawal; J Roberts; N Sharma; R Tutuian; M Vela; D O Castell
Journal:  Dis Esophagus       Date:  2009-02-13       Impact factor: 3.429

Review 7.  The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury.

Authors:  J A Koufman
Journal:  Laryngoscope       Date:  1991-04       Impact factor: 3.325

8.  Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?

Authors:  J Tack; G Koek; I Demedts; D Sifrim; J Janssens
Journal:  Am J Gastroenterol       Date:  2004-06       Impact factor: 10.864

9.  Can acid (pH) refluxes predict multichannel intraluminal impedance refluxes? A correlation study.

Authors:  Sudipta Misra
Journal:  J Gastroenterol Hepatol       Date:  2010-04       Impact factor: 4.029

Review 10.  Atypical presentations of gastroesophageal reflux disease.

Authors:  Joel J Heidelbaugh; Arvin S Gill; R Van Harrison; Timothy T Nostrant
Journal:  Am Fam Physician       Date:  2008-08-15       Impact factor: 3.292

View more
  5 in total

1.  Pathophysiology of Gastroesophageal Reflux in Patients with Chronic Pulmonary Obstructive Disease Is Linked to an Increased Transdiaphragmatic Pressure Gradient and not to a Defective Esophagogastric Barrier.

Authors:  Leonardo M Del Grande; Fernando A M Herbella; Amilcar M Bigatao; Henrique Abrao; Jose R Jardim; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2015-09-24       Impact factor: 3.452

Review 2.  Pathophysiology of gastroesophageal reflux disease: how an antireflux procedure works (or does not work).

Authors:  Fernando A M Herbella; Francisco Schlottmann; Marco G Patti
Journal:  Updates Surg       Date:  2018-07-23

Review 3.  Gastroesophageal reflux disease and non-esophageal cancer.

Authors:  Fernando A M Herbella; Sebastião Pannocchia Neto; Ilka Lopes Santoro; Licia Caldas Figueiredo
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

4.  Minor psychiatric disorders and objective diagnosis of gastroesophageal reflux disease.

Authors:  Rafael Melillo Laurino Neto; Fernando A M Herbella; Andre Zugman; Vic Velanovich; Beth Montera; Francisco Schlottmann; Marco G Patti
Journal:  Surg Endosc       Date:  2019-02-27       Impact factor: 4.584

5.  Importance of esophageal manometry and pH monitoring for the evaluation of otorhinolaryngologic (ENT) manifestations of GERD. A multicenter study.

Authors:  Fernando A M Herbella; Ciro Andolfi; Yalini Vigneswaran; Marco G Patti; Bruno R Pinna
Journal:  J Gastrointest Surg       Date:  2016-07-25       Impact factor: 3.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.